News and Views

The gift from an anonymous donor anchors the construction funding for a new building complex on the Scripps California campus.

The drug candidate under development by the Roberts and Rosen labs may be able to prevent the onset of stress-induced migraines.

“We want our work to really help patients, to really make a positive difference,” says TSRI Professor Jerold Chun.

Study by TSRI and Janssen Makes Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Scientists Show How Aging Cripples the Immune System, Suggesting Benefits of Antioxidants
Team Finds a Better Way to Engineer Therapeutic Proteins into Antibodies
International Team Discovers the Ancient Origins of Deadly Lassa Virus
Team Makes Strides in Therapy Preventing Addiction Relapse by Erasing Drug-Associated Memories
Technology Meets Teamwork: Andrew Ward Unlocks Viruses’ Secrets
Team Finds New Antibody Weapons against Marburg Virus
Scientists Pinpoint Mechanism for Altered Pattern of Brain Growth in Autism Spectrum Disorder
TSRI-Designed Drug Candidate Significantly Reduces HIV Reactivation Rate
Chemists Find Efficient, Scalable Way to Synthesize Potential Brain-Protecting Compound
AIDS Vaccine Candidate Successfully ‘Primes’ Immune System
Scientists Identify a Potential New Treatment for Osteoporosis
New Close-Up View Reveals Key Part of Ebola Virus Life Cycle
Team Shows Antitumor Agent Can Be Activated by Natural Response to Cell Stress
Study: Hormone ‘Erases’ Male Smell for Female Mice